SMTL ID : 5f60.1

Crystal structure of the first bromodomain of human BRD4 in complex with SG3-014

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.35 Å

Oligo State

monomer

Ligands

1 x 5VZ: ~{N}-[2-chloranyl-5-[[5-methyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]amino]phenyl]-2-methyl-propane-2-sulfonamide(Non-covalent)

5VZ.1: 15 residues within 4Å: Chain A: W.40, P.41, F.42, Q.44, V.46, L.51, L.53, Y.56, C.95, Y.98, N.99, D.104, I.105, M.108 Ligands: EDO.4 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:W.40, A:P.41, A:P.41, A:F.42, A:V.46, A:L.51, A:L.53, A:L.53, A:Y.98, A:D.104, A:I.105 Hydrogen bonds: A:P.41, A:N.99, A:N.99 Water bridges: A:Y.56, A:I.105

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.2: 5 residues within 4Å: Chain A: V.28, L.115, Q.118, K.119, E.122 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.119 Water bridges: A:E.122

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 7 residues within 4Å: Chain A: I.59, I.60, K.61, T.62, T.90, N.94, I.97 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:I.59, A:K.61, A:T.62, A:T.62, A:N.94 EDO.4: 7 residues within 4Å: Chain A: Q.44, P.45, V.46, D.47, K.50, L.51 Ligands: 5VZ.1 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:D.47 Water bridges: A:Q.44, A:P.45, A:D.47 EDO.5: 5 residues within 4Å: Chain A: P.101, G.102, V.106, L.107, E.110 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:G.102 Water bridges: A:E.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ember, S.W. et al., Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics. Mol. Cancer Ther. (2017)

Release Date

2017-02-08

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 4

Related Entries With Identical Sequence